The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor Charly Travers discuss topics across the investing world.

Charly has been looking for pharma stocks in Europe, and he's pleasantly surprised with some of the possibilities there. Novartis is one company he likes a lot. He discusses it here, along with his view of the long-term prospects for the company.

Charly Travers has no positions in the stocks mentioned above. John Reeves has no positions in the stocks mentioned above. The Motley Fool owns shares of Teva Pharmaceutical Industries. Motley Fool newsletter services recommend Novartis, Pfizer, and Teva Pharmaceutical Industries. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.